Publications by authors named "Bianca Lederer"

Claim this Profile
I
Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy.
Jens Huober, Marion van Mackelenbergh, Andreas Schneeweiss, Fenja Seither, Jens-Uwe Blohmer, Bianca Lederer

NPJ Breast Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.
Paul Jank, Claire Gehlhaar, Bianca Lederer, Caterina Fontanella, Andreas Schneeweiss

PLoS One· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of the CPS + EG scoring system in triple-negative breast cancer treated with neoadjuvant chemotherapy.
Frederik Marmé, Christine Solbach, Laura Michel, Andreas Schneeweiss, Jens-Uwe Blohmer, Bianca Lederer

Eur J Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors - An analysis of 2765 patients from neoadjuvant clinical trials.
Sonia L Villegas, Valentina Nekljudova, Nicole Pfarr, Jutta Engel, Michael Untch, Bianca Lederer

Eur J Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy.
Jenny Furlanetto, Volker Möbus, Andreas Schneeweiss, Kerstin Rhiem, Hans Tesch, Bianca Lederer

Eur J Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial.
Paul Jank, Claire Gehlhaar, Lederer Bianca, Fontanella Caterina, Schneeweiss Andreas

PLoS One· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane-Based Neoadjuvant Chemotherapy.
Sanxing Guo, Sibylle Loibl, Gunter von Minckwitz, Silvia Darb-Esfahani, Bianca Lederer

Cancer Res Treat· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Germline Variant Status With Therapy Response in High-risk Early-Stage Breast Cancer: A Secondary Analysis of the GeparOcto Randomized Clinical Trial.
Esther Pohl-Rescigno, Jan Hauke, Sibylle Loibl, Volker Möbus, Carsten Denkert, Bianca Lederer

JAMA Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatal events during clinical trials: an evaluation of deaths during breast cancer studies.
Jenny Furlanetto, Gunter von Minckwitz, Bianca Lederer, Volker Möbus, Andreas Schneeweiss

Breast Cancer· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials.
David Krug, Bianca Lederer, Fenja Seither, Valentina Nekljudova, Beyhan Ataseven

Ann Surg Oncol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Nuclear Oestrogen Receptor Beta Expression in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
Florian Heitz, Sherko Kümmel, Bianca Lederer, Christine Solbach, Knut Engels

Geburtshilfe Frauenheilkd· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated with Neoadjuvant Therapy in the GeparQuinto Trial.
Malgorzata Banys-Paluchowski, Sibylle Loibl, Isabell Witzel, Christoph Mundhenke, Bianca Lederer

Cancers (Basel)· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical relevance and concordance of HER2 status in local and central testing-an analysis of 1581 HER2-positive breast carcinomas over 12 years.
Berit M Pfitzner, Bianca Lederer, Judith Lindner, Christine Solbach, Knut Engels

Mod Pathol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome after neoadjuvant chemotherapy in elderly breast cancer patients - a pooled analysis of individual patient data from eight prospectively randomized controlled trials.
Gabriel von Waldenfels, Sibylle Loibl, Jenny Furlanetto, Anna Machleidt, Bianca Lederer

Oncotarget· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
Carsten Denkert, Gunter von Minckwitz, Silvia Darb-Esfahani, Bianca Lederer, Barbara I Heppner

Lancet Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Mutation Status, Pathological Complete Response, and Disease-Free Survival in Triple-Negative Breast Cancer: Secondary Analysis of the GeparSixto Randomized Clinical Trial.
Eric Hahnen, Bianca Lederer, Jan Hauke, Sibylle Loibl, Sandra Kröber

JAMA Oncol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
pCR rates in patients with bilateral breast cancer after neoadjuvant anthracycline-taxane based-chemotherapy - A retrospective pooled analysis of individual patients data of four German neoadjuvant trials.
Mattea Reinisch, Jens Huober, Gunter von Minckwitz, Jens-Uwe Blohmer, Carsten Denkert, Bianca Lederer

Breast· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory Cost-Effectiveness Analysis of Response-Guided Neoadjuvant Chemotherapy for Hormone Positive Breast Cancer Patients.
Anna Miquel-Cases, Valesca P Retèl, Bianca Lederer, Gunter von Minckwitz, Lotte M G Steuten

PLoS One· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer.
Barbara Ingold Heppner, Michael Untch, Carsten Denkert, Berit M Pfitzner, Bianca Lederer

Clin Cancer Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Analysis of PTEN and p4EBP1 Protein Expression as Predictors for pCR in HER2-Positive Breast Cancer.
Sibylle Loibl, Silvia Darb-Esfahani, Jens Huober, Alexander Klimowicz, Jenny Furlanetto, Bianca Lederer

Clin Cancer Res· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utility of the CPS+EG staging system in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer treated with neoadjuvant chemotherapy.
Frederik Marmé, Bianca Lederer, Jens-Uwe Blohmer, Serban Dan Costa, Carsten Denkert

Eur J Cancer· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardized Ki67 Diagnostics Using Automated Scoring--Clinical Validation in the GeparTrio Breast Cancer Study.
Frederick Klauschen, Stephan Wienert, Wolfgang D Schmitt, Sibylle Loibl, Bernd Gerber, Bianca Lederer

Clin Cancer Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome after neoadjuvant chemotherapy in young breast cancer patients: a pooled analysis of individual patient data from eight prospectively randomized controlled trials.
Sibylle Loibl, Christian Jackisch, Bianca Lederer, Michael Untch, Stefan Paepke

Breast Cancer Res Treat· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials.
Caterina Fontanella, Bianca Lederer, Stephan Gade, Mieke Vanoppen, Jens Uwe Blohmer

Breast Cancer Res Treat· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of breast cancer patients with chemotherapy-induced neutropenia or febrile neutropenia.
Caterina Fontanella, Silvia Bolzonello, Bianca Lederer, Giuseppe Aprile

Breast Care (Basel)· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis